Spike protein-induced VSIR-ISX signaling disrupts metabolic homeostasis and promotes COVID-19-related immune

Li-Ting Wang1, Shen-Nien Wang2,3,4,5, Shyh-Shin Chiou6,7

  • 1Department of Life Science, National Taiwan Normal University, Taipei, Taiwan.

Cell Biology and Toxicology
|December 19, 2025
PubMed

Insights

The SARS-CoV-2 Spike protein disrupts metabolism via the VSIR-ISX pathway, impacting tryptophan and arachidonic acid pathways. Targeting this axis offers a potential therapeutic strategy for COVID-19.

Area of Science:

  • Molecular Biology
  • Immunology
  • Metabolic Research

Background:

  • COVID-19, caused by SARS-CoV-2, has led to significant global mortality.
  • Vaccine effectiveness is waning due to emerging viral variants, necessitating novel antiviral treatments.
  • Understanding virus-host interactions is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the mechanism by which the SARS-CoV-2 Spike protein (SARS-2-S) induces metabolic disturbances.
  • To identify the role of the VSIR-ISX signaling pathway in SARS-CoV-2-mediated metabolic alterations.
  • To explore the VSIR-ISX pathway as a potential therapeutic target for COVID-19.

Main Methods:

  • RNA sequencing to analyze gene expression changes in pulmonary cells.
  • Chromatin immunoprecipitation and genome sequencing to identify ISX binding sites.
  • Utilized shRNA interference and NF-κB inhibitors to disrupt the VSIR-ISX axis.

Main Results:

  • SARS-2-S expression activates genes in tryptophan and arachidonic acid (AA) metabolism, altering kynurenine and prostanoid levels.
  • The ACE2-MYD88 pathway, activated by SARS-2-S, enhances the VSIR-ISX axis via NF-κB signaling.
  • ISX directly binds to gene promoters, upregulating enzymes involved in AA metabolism.
  • Disruption of the VSIR-ISX axis mitigated SARS-2-S-induced metabolic disturbances.

Conclusions:

  • The VSIR-ISX signaling pathway is a key mediator of SARS-CoV-2-induced metabolic dysregulation.
  • Targeting the VSIR-ISX axis may offer a novel therapeutic strategy for managing COVID-19.
  • Intervention in metabolic pathways offers a new avenue for antiviral therapy development.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.8K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
52.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K